VYGORIS
LIVE

Serial Number

79231304

Owner

Vygoris Limited

Filing Date

Jan 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

VYGORIS Trademark

Serial Number: 79231304 • Registration: 5815746

VYGORIS is a trademark filed by Vygoris Limited on January 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Vygoris Limited

930 High Road

Entity Type: 99

SUBSTIPHARM

24, rue Erlanger

Entity Type: 99

Trademark Details

Filing Date

January 16, 2018

Registration Date

July 30, 2019

Published for Opposition

December 11, 2018

Cancellation Date

February 13, 2026

Goods & Services

Medicinal, pharmaceutical, and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; radioactive substances for medical purposes; dietary supplements for humans and animals; pharmaceutical preparations and medical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicines and pharmaceuticals for use in oncology; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, available on prescription only; pharmaceutical preparations available on prescription only, namely, cytostatics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in urology; and pharmaceutical products for the prevention and treatment of cancer

Filing History

CANCELLED SECTION 71
Feb 13, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 30, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Mar 15, 2024 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Nov 5, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 16, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2019 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 20, 2019 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 10, 2019 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 11, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 11, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Dec 8, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 21, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 21, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 21, 2018 NONP
ASSIGNED TO LIE
Nov 1, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 9, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 18, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 18, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 17, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 16, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
May 12, 2018 MAFR
ASSIGNED TO EXAMINER
May 8, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 3, 2018 REPR